Please check your internet connection and try again.
# Diloxanide Furoate
## Overview
Diloxanide furoate is an amebicide used to treat intestinal amebiasis. Its mechanism of action is not fully understood but is thought to involve disruption of parasitic protein synthesis.
## Primary Indications
* Asymptomatic intestinal amebiasis (luminal amebicide).
* Treatment of mild to moderate intestinal amebiasis.
## Adult Dosing
* **Usual dose:** 500 mg orally every 8 hours for 7 to 10 days.
* **Maximum dose:** Not specified, but prolonged or repeated courses may be necessary.
## Pediatric Dosing
* **Children 1-12 years:** 10 mg/kg orally every 8 hours for 7 to 10 days, not to exceed the adult dose.
## Dose Adjustments
No specific dose adjustments are recommended for renal or hepatic impairment.
## Contraindications
* Known hypersensitivity to diloxanide furoate.
* Use with caution in patients with severe hepatic or renal disease.
## Adverse Effects
* Gastrointestinal: Nausea, vomiting, abdominal cramps, diarrhea.
* Other: Flatulence, pruritus, rash, urticaria.
## Key Drug Interactions
No significant drug interactions are established.
## Monitoring
* Monitor for signs and symptoms of amebiasis, including diarrhea and abdominal pain.
* Assess for resolution of infection and potential recurrence.
## Clinical Pearls
* Diloxanide furoate is primarily effective against the luminal trophozoite and cyst forms of *Entamoeba histolytica*.
* It is often used in combination with other agents (e.g., metronidazole) for invasive amebiasis or amebic liver abscess.
* Ensure adequate hydration and nutritional support during treatment.
***
*This information is intended for healthcare professionals. Always verify current prescribing information with the official drug labeling and relevant guidelines before dispensing or administering any medication.*